These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 24931587

  • 1. Exercise limitation of acetazolamide at altitude (3459 m).
    Bradwell AR, Myers SD, Beazley M, Ashdown K, Harris NG, Bradwell SB, Goodhart J, Imray CH, Wimalasena Y, Edsell ME, Pattinson KT, Wright AD, Harris SJ, Birmingham Medical Research Expeditionary Society.
    Wilderness Environ Med; 2014 Sep; 25(3):272-7. PubMed ID: 24931587
    [Abstract] [Full Text] [Related]

  • 2. The effect of acetazolamide on saccadic latency at 3459 meters.
    Faull OK, Robertson J, Thomas O, Bradwell AR, Antoniades CA, Pattinson KT, Birmingham Medical Research Expeditionary Society.
    Wilderness Environ Med; 2015 Mar; 26(1):72-7. PubMed ID: 25712298
    [Abstract] [Full Text] [Related]

  • 3. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).
    Carlsten C, Swenson ER, Ruoss S.
    High Alt Med Biol; 2004 Mar; 5(1):33-9. PubMed ID: 15072715
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Altitude, Acute Mountain Sickness, and Acetazolamide: Recommendations for Rapid Ascent.
    Toussaint CM, Kenefick RW, Petrassi FA, Muza SR, Charkoudian N.
    High Alt Med Biol; 2021 Mar; 22(1):5-13. PubMed ID: 32975448
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
    Basnyat B, Gertsch JH, Johnson EW, Castro-Marin F, Inoue Y, Yeh C.
    High Alt Med Biol; 2003 Mar; 4(1):45-52. PubMed ID: 12713711
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
    van Patot MC, Leadbetter G, Keyes LE, Maakestad KM, Olson S, Hackett PH.
    High Alt Med Biol; 2008 Mar; 9(4):289-93. PubMed ID: 19115912
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sleeping in moderate hypoxia at home for prevention of acute mountain sickness (AMS): a placebo-controlled, randomized double-blind study.
    Dehnert C, Böhm A, Grigoriev I, Menold E, Bärtsch P.
    Wilderness Environ Med; 2014 Sep; 25(3):263-71. PubMed ID: 24931591
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Residence at Moderate Versus Low Altitude Is Effective at Maintaining Higher Oxygen Saturation During Exercise and Reducing Acute Mountain Sickness Following Fast Ascent to 4559 m.
    Bernardi E, Pomidori L, Cavallari D, Mandolesi G, Cogo A.
    Wilderness Environ Med; 2017 Jun; 28(2):122-126. PubMed ID: 28455198
    [Abstract] [Full Text] [Related]

  • 14. The Effects of Acetazolamide on Exercise Performance at Sea Level and in Hypoxic Environments: A Review.
    Posch AM, Dandorf S, Hile DC.
    Wilderness Environ Med; 2018 Dec; 29(4):541-545. PubMed ID: 30314664
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
    Berger MM, Sareban M, Schiefer LM, Swenson KE, Treff F, Schäfer L, Schmidt P, Schimke MM, Paar M, Niebauer J, Cogo A, Kriemler S, Schwery S, Pickerodt PA, Mayer B, Bärtsch P, Swenson ER.
    J Appl Physiol (1985); 2022 Jun 01; 132(6):1361-1369. PubMed ID: 35511718
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Patients with Obstructive Sleep Apnea Have Cardiac Repolarization Disturbances when Travelling to Altitude: Randomized, Placebo-Controlled Trial of Acetazolamide.
    Latshang TD, Kaufmann B, Nussbaumer-Ochsner Y, Ulrich S, Furian M, Kohler M, Thurnheer R, Saguner AM, Duru F, Bloch KE.
    Sleep; 2016 Sep 01; 39(9):1631-7. PubMed ID: 27306264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.